| Autor: |
Nicholas D. Brownstone, MD, Aaron S. Farberg, MD, Graham H. Litchman, DO, MS, Ann P. Quick, PhD, Jennifer J. Siegel, PhD, Lenka V. Hurton, PhD, Matthew S. Goldberg, MD, Peter A. Lio, MD |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
JAAD International, Vol 16, Iss , Pp 49-56 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2666-3287 |
| DOI: |
10.1016/j.jdin.2024.03.019 |
| Popis: |
Background: Empirical decisions to select therapies for psoriasis (PSO) and atopic dermatitis (AD) can lead to delays in disease control and increased health care costs. However, routine molecular testing for AD and PSO are lacking. Objective: To examine (1) how clinicians choose systemic therapies for patients with PSO and AD without molecular testing and (2) to determine how often the current approach leads to patients switching medications. Methods: A 20-question survey designed to assess clinician strategies for systemic treatment of AD and PSO was made available to attendees of a national dermatology conference in 2022. Results: Clinicians participating in the survey (265/414, 64% response rate) ranked “reported efficacy” as the most important factor governing treatment choice (P |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
